COMMUNIQUÉS West-GlobeNewswire

Orbus Therapeutics Highlights Phase 3 STELLAR Clinical Study Results Showing Clinically Meaningful Benefits in Rare Brain Tumor at Society for Neuro-Oncology (SNO) Annual Meeting
20/11/2025
– Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful survival benefits for patients with recurrent grade 3 astrocytoma who were treated with [...]
SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference
20/11/2025
DENVER, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]
Navigator Medicines Completes Last Participant Last Visit (LPLV) in Phase 1b Trial of NAV-240, an OX40L and Anti-TNFα Bispecific Antibody for Autoimmune Diseases
20/11/2025
Full Study Results Expected in Q1 2026 Further Clinical Development of NAV-240 in Hidradenitis Suppurativa to Begin in Early 2026 SCOTCH PLAINS, NJ., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Navigator Medicines Inc., a [...]
Life Backup Plan Rolls Out New Version During Medicare Open Enrollment Season and Employer Benefits Review
20/11/2025
New release introduces unparalleled digital medical history and clinical intake capabilities, supporting hospitals, employers, individuals, families, and health insurers—and opens limited Showcase Partner slots for a [...]
Déclaration Intermédiaire Troisième Trimestre : IBA très confiante dans la réalisation de sa guidance 2025, renforcement de la structure de financement
20/11/2025
Louvain-la-Neuve, Belgique, le 20 novembre 2025 - IBA (Ion Beam Applications SA), le leader mondial des technologies d’accélération de particules, publie aujourd'hui la revue de ses activités pour le troisième trimestre [...]
Third quarter 2025 update: IBA is highly confident to meet FY2025 guidance, and strengthens financing structure
20/11/2025
Louvain-la-Neuve, Belgium, 20 November 2025 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, shares its business update for the third quarter of 2025. Group Overview Equipment order [...]
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline assets
20/11/2025
Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance rolled forward to +5-6% cc CAGR for 2025-2030, following upgrade of 2024-2029 guidance to +6% cc 1 Peak sales guidance upgraded for Kisqali and Scemblix [...]
Valneva publie ses résultats financiers des neuf premiers mois de 2025 et fait un point sur ses activités
20/11/2025
Chiffre d’affaires de 127,0 millions d’euros contre 116,6 millions d’euros sur les neuf premiers mois de 2024 Trésorerie de 143,5 millions d’euros à fin septembre 2025 Flexibilité financière accrue grâce au succès du [...]
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
20/11/2025
Total revenues of €127.0 million compared to €116.6 million in the first nine months of 2024 Cash and cash equivalents of €143.5 million at end of September 2025 Financial flexibility enhanced with successful debt [...]
Burning Rock Reports Third Quarter 2025 Financial Results
20/11/2025
GUANGZHOU, China, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the [...]
IMU Biosciences Appoints Dr. Carlos Paya as Non-Executive Director, Strengthening its Board of Directors
20/11/2025
PRESS RELEASE London, UK, 20 November 2025 — IMU Biosciences (or “the Company”), a biotechnology company decoding the immune system to drive next generation health outcomes, today announced the appointment of Dr. Carlos [...]
Concept Life Sciences Presents New Data Advancing Neuroinflammation and Neurodegeneration Research at Neuroscience 2025
20/11/2025
Three posters highlight advances in inflammasome inhibition, astrocyte neurotoxicity, and myelination models supporting translational drug discovery CHAPEL-EN-LE-FRITH, United Kingdom, Nov. 20, 2025 (GLOBE NEWSWIRE) -- [...]
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
20/11/2025
REYKJAVIK, Iceland and LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and [...]
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
20/11/2025
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered [...]
Extendicare to Expand its Home Health Care Business by Acquiring CBI Home Health for $570 Million in Cash Consideration
19/11/2025
Extendicare also announces $200 million bought deal private placement equity offering Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, ONTARIO, Nov. 19, 2025 (GLOBE [...]
Apollomics Announces Settlement of Cayman Litigation
19/11/2025
FOSTER CITY, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”) (Nasdaq: APLM) announced today entering into a settlement agreement (the “Settlement Agreement” or the “Agreement”) [...]
Profusa Announces Third Quarter Business and Financial Highlights
19/11/2025
Recapitalization reduced net debt to $14 million as of October 31; achieved key milestones to deliver potential 2026 revenue target BERKELEY, Calif, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “ [...]
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
20/11/2025
HOUSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the [...]
Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID’s New AI-Powered Feature
20/11/2025
TORBAL DIVISION SALES UP 15% YTD LAUNCH OF VIVID’S FIRST AI-POWERED FEATURE SECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR Q1 CY26 Investor Call to be held Thursday, November 20 th at 11:00 a.m. Eastern Time BOHEMIA, [...]

Pages